Cerebral Embolization After Implantation of a Balloon-Expandable Aortic Valve Without Prior Balloon Valvuloplasty: When Is Doing Less More?

Transcatheter aortic valve replacement (TAVR) is an established therapeutic option for patients with severe symptomatic aortic stenosis. However, the periprocedural stroke rate continues to be relatively high, ranging between 3% and 5% in randomized clinical trials and large registries [(1,2)][1].